Evangelos Galitis DDS, MSc TMD specialist, MScc Dentoalveolar Surgery


Short Resume

Dr Evan graduated with honors from the Hellenic-American Educational Foundation, Athens College, in 2003 and then from the Dental School of Athens in 2008. In 2009-2011 he worked for the National Health System of England performing more than 10,000 dental treatments and prosthetic operations. At the same time he studied implantology at Trafford General Hospital. Upon his return to Greece, he began the three-year Master's Program of Specialization in the Oral Pain Management Clinic, at the School of Dentistry of the National and Kapodistrian University of Athens. He received the Master of Science in Oral Oncology, on the topic:

 

Effect of postoperative radiation therapy, with or without chemotherapy, on the function of the oromandibular system and the quality of life in patients with squamous cell carcinoma of the mouth. Athens 2017.

 

Currently he is a final year student in the three-year Master's Program entitled "Oral Pathology, Surgery and Radiology" with a specialization in Dentoalveolar Surgery.


Scientific work

He collaborated in the research projects:

·                Development of an Oral Health Quality of Life Module, phase I to IV of the EORTC Module development, http://groups.eortc.be

·                Update of the EORTC QLQ-H&N35, Phase I/III, Head and Neck Quality of Life Questionnaire Module, http://groups.eortc.be/qol

 

Publications:

  1. Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients. Nicolatou-Galitis, O.; Psyrri, A.; Tsoukalas, N.; Galitis, E.; Linardou, H.; Galiti, D.; Athansiadis, I.; Kalapanida, D.; Razis, E.; Katirtzoglou, N.; Kentepozidis, N.; Kosmidis, P.; Stavridi, F.; Kyrodimos, E.; Daliani, D.; Tsironis, G.; Mountzios, G.; Karageorgopoulou, S.; Gouveris, P.; Syrigos, K. Oral 2023, 3, 123-133. https://doi.org/10.3390/oral3010011
  2. Oral mucositis-related neuropathic pain in head and neck cancer patients receiving radiotherapy or chemo-radiotherapy. A prospective study. Kouri M, Nicolatou Galitis O, Vadalouca A, Kouloulias V, Papadopoulou E, Vardas E, Kyrodimos E, Trichas M, Zygogianni A, Liakouli Z, Galitis E, Siafaka I, Kougioumtzopoulou A, Psyrri A. J. J BUON. 2021 Sep-Oct;26(5):2010-2018. PMID: 34761611. 
  3. Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents. Nicolatou-Galitis O, Papadopoulou E, Vardas E, Kouri M, Galiti D, Galitis E, Alexiou KE, Tsiklakis K, Ardavanis A, Razis E, Athanasiadis I, Droufakou S, Psyrri A, Karamouzis MV, Linardou H, Daliani D, Tzanninis D, Sachanas S, Laschos K, Kyrtsonis MC, Antoniou F, Laskarakis A, Giassas S, Nikolaidi A, Rigakos G, Ntokou A, Migliorati CA, Ripamonti CI. Oral Dis. 2020 Jul;26(5):955-966. doi: 10.1111/odi.13294. Epub 2020 Mar 3. PMID: 32011077.
  4. The effect of post-operative radiotherapy, with or without chemotherapy, on the function of oromaxillofacial system and on the quality of life in patients with oral squamous cell carcinoma. E. Galitis. Master’s Thesis, Athens 2017.
  5. Trismus and reduced quality of life in patients with oral squamous cell carcinoma, who receive post-operative radiotherapy alone or combined with chemotherapy. E. Galitis, V. Droukas, V. Psarras, D. Galiti, E. Kyrodimos, M. Trichas, A. Psyrri, N. Papadogeorgakis, M. Kouri, E. Beli, V. Kouloulias. Forum of Clinical Oncology, 2017.  
  6. Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:699-706
  7. Stomatitis, gingivitis and periodontal abscess in a patient with metastatic renal cell carcinoma receiving temsirolimus and bevacizumab: A cumulative toxicity? Nicolatou-Galitis O, Koutsoukos KA, Galitis E, Bamias A, Dimopoulos MA. Mediterranean Oncology Journal-MOJ 2014;1:45-49.
  8. Οστεονέκρωση της κάτω γνάθου σταδίου 2: Η οδοντική εξαγωγή στα πλαίσια της θεραπευτικής αντιμετώπισης. Γαλίτη Δ, Γαλίτης Ε, Αντωνίου Φ. Τα Νέα της Ογκολογίας. 2014;3:43

 

Announcements at International Conferences:

1.    Localized alveolar bone disease prior to dental extraction in cancer patients treated with antiresorptives: an early stage of osteonecrosis of the jaw (ONJ)? Erofili Papadopoulou, et al. O κος Γαλίτης συνεργάστηκε στην παρουσίαση, MASCC.org, Meeting in Washington, June 2017.

2.      Dental extractions as part of the management strategy in patients with solid cancers and pre-existing osteonecrosis of the jaw stage 2. Athanasiadis I, Galitis E, Galiti D, Antoniou F, Koutinos G, Tzaninis D, Nicolatou-Galitis O. MASCC/ISOO International Symposium on Supportive Care in Cancer. Miami, USA. June 26-28, 2014. http://mascc2014.meetingxpert.net

3.      Gingival and periodontal toxicity and osteonecrosis in patients receiving targeted therapies alone or combined with zolendronic acid: A case series and clinical implications. Nicolatou-Galitis O, Razis E, Galitis E, Tsimpoukis S, Koutsoukos K, Sgouros J, Soupos N, Nikolaidi A, Barbounis V, Migliorati C. MASCC/ISOO International Symposium on Supportive Care in Cancer. Miami, USA. June 26-28, 2014. http://mascc2014.meetingxpert.net

4.      Dental extractions in oncology patients receiving intravenous bisphosphonates. A case series report. Vardas E, Nicolatou-Galitis O, Papadopoulou E, Galiti D, Galitis E, Kouri M, Razi E, Anagnostopoulos N, Megalakaki K, Bafaloukos D. Berlin, Germany, June 2013.http://mascc2013.meetingxpert.net